Form 8-K - Current report:
SEC Accession No. 0000950170-24-134733
Filing Date
2024-12-10
Accepted
2024-12-09 21:22:00
Documents
13
Period of Report
2024-12-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgx-20241209.htm   iXBRL 8-K 41325
2 EX-99.1 mgx-ex99_1.htm EX-99.1 20550
3 GRAPHIC img133734535_0.jpg GRAPHIC 111350
  Complete submission text file 0000950170-24-134733.txt   341748

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mgx-20241209.xsd EX-101.SCH 26951
15 EXTRACTED XBRL INSTANCE DOCUMENT mgx-20241209_htm.xml XML 5108
Mailing Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608
Business Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608 (510) 871-4880
Metagenomi, Inc. (Filer) CIK: 0001785279 (see all company filings)

EIN.: 813909017 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41949 | Film No.: 241536896
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)